| Autor: |
P A, Vorob'ev, E V, Dergach, V B, Gerasimov, M V, Avksent'eva |
| Rok vydání: |
2001 |
| Předmět: |
|
| Zdroj: |
Terapevticheskii arkhiv. 73(8) |
| ISSN: |
0040-3660 |
| Popis: |
To estimate cost-effect efficacy of vasaprostan treatment of inpatients with arterial chronic obliteration (ACO) with critical ischemia of the lower limbs (Fonten stage III-IV).Case histories of 105 ACO patients with critical ischemia of the lower limbs (mean age 65 +/- 11.8 years) were analysed to compare efficacy and cost of the "typical practice" of hospital treatment of such patients with prognostic cost of basaprostan treatment using drug-cost modeling.The cost-effect analysis comparing efficacy of "typical practice" and vasaprostan treatment showed that in "typical practice" amputations of the limb are inevitable in 41% while vasaprostan treatment reduces the percentage of the operations to 8.6-12% (according to the literature); overall cost of the "typical" treatment for 105 patients reached 3,909,222 roubles while relevant prognostic cost of vasaprostan treatment made up 4,407,162-4,570,653 roubles. Thus, vasaprostan treatment is characterized by less expense per 1 case of the limb amputation prevention vs "typical practice".The models used demonstrated that vasaprostan treatment is more cost-effective than "typical practice". |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
